文献速递疼痛医学

亚感知阈值背根神经节刺激与假刺激在既定应答者中的随机双盲交叉试验

Subperception dorsal root ganglion stimulation versus sham stimulation in established responders: a randomized, double-blind crossover clinical trial.
PubMed 文献 · Reg Anesth Pain Med · 2026-05-13

该单中心随机双盲假刺激对照交叉试验纳入20例已植入背根神经节刺激系统且持续应答的慢性疼痛成人,比较亚感知阈值刺激与关闭刺激的5天治疗期。结果显示活性刺激期疼痛评分中位数3.0显著低于假刺激期6.0,患者满意度及整体变化印象均 favoring 活性刺激,无严重或器械相关不良事件。

要点

  • 在既定DRG刺激应答者中,亚感知阈值刺激较假刺激显著降低疼痛评分。
  • 患者满意度及PGIC各域均支持活性刺激优于假刺激。
  • 结论外推至未选择的慢性疼痛人群或治疗早期阶段受限。

核心结论

  • 在既定背根神经节刺激应答者中,亚感知阈值刺激相较假刺激产生有临床意义的疼痛缓解并改善患者报告结局。

研究设计与样本

  • 单中心随机双盲假刺激对照交叉试验,采用富集入组设计,纳入20例已植入DRG系统且持续应答(疼痛缓解≥50%持续≥3个月)的慢性周围神经病理性或伤害可塑性疼痛成人。

主要发现

  • 活性刺激期疼痛强度中位NRS 3.0(IQR 2.0-4.0)低于假刺激期6.0(IQR 4.0-7.0),Hodges-Lehmann中位差-2.5(95%CI -3.0至-2.0;p<0.001)。
  • 患者满意度及所有PGIC域均 favoring 活性刺激。
  • 两名参与者按预设标准提前终止一个治疗期,可用数据保留;未报告严重或器械相关不良事件。

关键数值与推荐

  • 活性刺激强度为感知阈值的90%,假刺激为刺激关闭。
  • 两个5天治疗期之间设24小时洗脱期(刺激关闭)。
  • 主要结局为0-10数字评定量表的中位疼痛强度。

临床怎么用

  • 对于已从DRG刺激中持续获益的患者,维持期可考虑使用亚感知阈值刺激以减轻疼痛并改善满意度。
  • 结果不支持将结论直接推广至未选择的慢性疼痛人群或治疗早期阶段。

局限性

  • 样本量小(20例),单中心设计。
  • 结论外推至未选择的慢性疼痛人群或治疗早期阶段受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: subperception (paresthesia-free) dorsal root ganglion (DRG) stimulation is increasingly used for focal neuropathic pain, but sham-controlled evidence remains limited. We conducted a randomized, double-blind, sham-controlled crossover trial with enriched enrollment design in established DRG-stimulation responders. METHODS: In this single-center trial, adults with chronic peripheral neuropathic or nociplastic pain with implanted DRG system and sustained response (≥50% pain reduction for ≥3 months on stable stimulation settings and medication) were randomized 1:1 to active→sham or sham→active stimulation. Participants completed two 5-day treatment periods separated by a 24-hour washout with stimulation off. Active stimulation was delivered at 90% of the perception threshold, and sham was stimulation off. The primary outcome was median pain intensity on a 0-10 Numeric Rating Scale (NRS). Secondary outcomes included patient satisfaction and Patient Global Impression of Change (PGIC) domains. Analyses used Wilcoxon signed-rank tests with Hodges-Lehmann estimates. RESULTS: In 20 randomized patients, pain intensity was lower during active than sham stimulation (median NRS 3.0 (IQR 2.0-4.0) vs 6.0 (IQR 4.0-7.0); Hodges-Lehmann median difference, -2.5; 95% CI -3.0 to -2.0; p<0.001). Patient satisfaction and all PGIC domains favored active stimulation. Two participants terminated one treatment period early per prespecified criteria; available data were retained. No serious or device-related adverse events were reported. CONCLUSIONS: In established DRG responders, subperception DRG stimulation produced clinically meaningful pain reduction and improved patient-reported outcomes compared with sham. These findings support efficacy during the maintenance phase of treatment, but their generalizability to unselected chronic pain populations or earlier treatment phases is limited. TRIAL REGISTRATION NUMBER: NCT07170722.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Tabatabaei P, Wänman J, Awad A, et al. Subperception dorsal root ganglion stimulation versus sham stimulation in established responders: a randomized, double-blind crossover clinical trial. Reg Anesth Pain Med. 2026. PMID: 42128597. doi:10.1136/rapm-2026-107906

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。